Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.54
- Piotroski Score 5.00
- Grade Buy
- Symbol (MYTE)
- Company MYT Netherlands Parent B.V.
- Price $7.00
- Changes Percentage (-0.29%)
- Change -$0.02
- Day Low $6.57
- Day High $7.13
- Year High $8.24
MYT Netherlands Parent B.V., through its subsidiary, Mytheresa Group GmbH, operates a luxury e-commerce platform for fashion consumers in Germany, the United States, the rest of Europe, and internationally. The company sells clothes, bags, shoes, accessories, and fine jewelry through online and retail stores. It serves high-income luxury consumers. The company was founded in 1987 and is based in Munich, Germany.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/19/2024
- Fiscal Year End N/A
- Average Stock Price Target $16.00
- High Stock Price Target $25.00
- Low Stock Price Target $3.75
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.32
- Trailing P/E Ratio -19.03
- Forward P/E Ratio -19.03
- P/E Growth -19.03
- Net Income $-24,911,000
Income Statement
Quarterly
Annual
Latest News of MYTE
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Here's Why We're Not At All Concerned With MYT Netherlands Parent B.V's (NYSE:MYTE) Cash Burn Situation
Shareholders can profit from a business even if it's losing money if they buy at the right price. Analyzing MYT Netherlands Parent B.V's cash burn, it seems well-positioned to raise more cash and cont...
By Yahoo! Finance | 2 months ago -
MyTech Group Berhad Full Year 2024 Earnings: EPS: RM0.011 (vs RM0.005 in FY 2023)
MyTech Group Berhad's profit margin rose to 24% from 11% in FY 2023, driven by increased revenue. Manufacturing segment contributed RM9.68m (93% of revenue), while General & Administrative costs were ...
By Yahoo! Finance | 3 months ago -
Jaguar Health shares slump following Phase III Mytesi failure
Jaguar Health's anti-diarrheal drug Mytesi did not meet its primary endpoint in a Phase III trial for cancer patients, causing shares to drop. The company plans to engage with the FDA for further anal...
By Yahoo! Finance | 3 months ago
